European Journal of Heart Failure 2006 8(2):223-224; doi:10.1016/j.ejheart.2006.01.014
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2006 European Society of Cardiology
Corrigendum to "Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta-analysis" [Eur J Heart Fail 7 (2005) 1133—1144]
a Population Health Research Institute, McMaster University, and Hamilton Health Sciences Hamilton, Ontario, Canada
b Cardiology Department, S. Raffaele Hospital Milan, Italy
c Division of Cardiology, McMaster University Hamilton, Ontario, Canada
d Department of Epidemiology and Biostatistics, McMaster University Hamilton, Ontario, Canada
* Corresponding author. Viale Abruzzi, 90, 20131 Milan, Italy. Tel./fax: +39 02 29512491. E-mail address: rosaroccaforte{at}hotmail.com
Received June 15, 2005; Accepted August 22, 2005
The Authors and Publisher regret to inform you that in the originally published article, the incorrect version of Figures 4 and 6 were used. Please find the correct versions over. Please note the following text from the authors with respect to Figure 6:
|
|
"Our paper appeared as an "article in press" on the Journal website on September 29, 2005, and since then we received several comments by your readers. One of the readers raised some questions about Figure 6 and the data shown in it (page 1140 of the printed version) and we decided to review our original analysis. We realised the raw data were entered in the analysis programme in a wrong way, so that the derived results were mistakenly interpreted as if they favoured the control treatment and not the intervention — the disease management programmes (DMP). However, this error did not materially affect the overall conclusion of the paper. Instead, after rectifying the error, the revised analysis provides an estimate of the intervention effect that even more clearly favours DMP. Specifically, the number of patients NOT receiving ACE-inhibitors is significantly lower in the intervention (DMP) group than in the control (usual care) group, that is DMP favours the use of ACE-inhibitors: odds ratio=0.69 (95% confidence interval: 0.56-0.86, p=0.0007)."
Apologies for any inconvenience caused.
![]()
CiteULike
Connotea
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

